TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
UPSC | Exam ScheduleExam Mentor
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | ChinaUnited StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
News Columns | Straight DriveCanada CallingLondon LetterKashmir AngleJammu JournalInside the CapitalHimachal CallingHill View
Don't Miss
Advertisement

Majithia:Pharma firm given favours

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement
Advertisement

Majithia:Pharma firm given favours

Advertisement

n Majithia said when it came to light that buprenorphine tablets were being diverted illegally, the Health Secretary ordered an inquiry, but Health Minister Balbir Singh Sidhu over-ruled him and sought report from civil surgeons

Advertisement

n He said that in January, Sidhu tried to close the case by issuing a warning to erring officials when the Secretary was on leave

n Majithia said the minister favoured Rusan Pharma that had been blacklisted after its medicines failed mandatory tests, but instead of taking action against the firm, it was relisted on the govt panel

Advertisement
Show comments
Advertisement